Hoxworth Blood Center

Cincinnati, Ohio 45267-0055

1 studies enrolling now · 22 studies all time

What they study most

Anemia, Anticoagulant Reversal, Blood Donors, Cardiovascular Diseases, Coagulopathy, Fibrosis, Focus of Study: Radiolabel Recovery and Survival of RBCs, Focus: Assess Post Infusion Viability of S303 RBCs, Freeze Dried Plasma in Healthy Volunteers, Granulocyte/ Polymorphonuclear Cells, Healthy, Healthy Apheresis Donors

Studies at this site

• A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1 — Recruiting now
• Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin — Withdrawn before enrolling
• A Study of Mosliciguat in PH-ILD — Running, not enrolling
• Ascending Dose Study of FrontlineODP™ Spray Dried Plasma — Completed
• In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days — Completed
• Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder — Completed
• Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution — Completed
• Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets — Completed
• Ascending Doses of Autologous FDP vs FFP — Completed
• Safety Study of ECO Conversion System For Red Blood Cells. — Completed
• Recovery and Lifespan of Red Blood Cells From Pathogen-reduced, Stored Blood Units — Status unconfirmed
• In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution — Completed
• Evaluation of Trima Version 7.0 Platelets in PAS — Completed
• Evaluation of Trima Version 7.0 Platelets in 100% Plasma — Completed
• A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study — Stopped early
• In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution — Completed
• DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma — Stopped early
• A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells — Completed
• An Evaluation of the Spectra Optia CMNC Collection Procedure — Completed
• Inactivation of Whole Blood With Mirasol — Completed
• Evaluation of the Spectra Optia PMN Cell Collection Procedure — Completed
• The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers — Completed